entity Updated 2026-07-12 Tags: Company, Life-Sciences, Vertical-Saas, Y-Combinator

Benchling

Benchling is the life-sciences software company discussed by Sajith Wickramasekara in Founder Mode: Sajith Wickramasekara, Founder & CEO, Benchling. Sajith describes it as software for scientific progress: scientists use it to design experiments, capture and analyze data, and share work with collaborators across universities, biotech companies, and pharma companies.

The source frames Benchling as a Life Sciences Workflow Software and Vertical SaaS Domain Expertise case. The founding insight came from Sajith’s MIT biology-lab work, where he saw scientific teams using paper, spreadsheets, and email even though software teams had modern collaboration systems. Y Combinator backed the company in Summer 2012 when it had many university users but no revenue; Paul Graham argued that becoming the default tool for biology workers could matter over time.

Benchling’s later scale makes it a Founder Mode operating case. Sajith says the company has about 600 people, offices in the Bay Area, Boston, and Europe, about 1,300 paying industry customers, and users across 7,000 universities. The source’s main company-building lesson is that scaling software for scientific work still depends on leaders staying close to customers and recognizing when imported executive playbooks weaken that connection.

Connections